Leader in Innovative Treatments
for Oxidative Stress

The company’s powerful, targeted therapies aim to stop oxidative tissue damage, a driver of blinding eye diseases and a broad spectrum of serious chronic conditions. Nacuity has several highly differentiated clinical programs, including retinitis pigmentosa, cataract, and cystinosis. Learn more About Us.
The company’s powerful, targeted therapies aim to stop oxidative tissue damage, a driver of blinding eye diseases and a broad spectrum of serious chronic conditions. Nacuity has several highly differentiated clinical programs, including retinitis pigmentosa, cataract, and cystinosis. Learn more About Us.